Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2021

View Archived Issues

AstraZeneca patents SLC12A5 activators

Minghui Pharmaceutical scientists synthesize new JAK inhibitors

Evotec presents ISR pathway modulators

MCT4 is a prognostic marker in anaplastic thyroid cancer

Merck KGaA and Ryvu Therapeutics divulge new ACSS2 inhibitors

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

SG-3-00802 shows encouraging preclinical activity in combination with anti-PD-1 therapy

HC-070 attenuates stress-related excessive sensitivity to aversion and apathy for reward in mice

Stealth's SBT-272 shows promise in murine model of ALS

Development of cell-penetrating asymmetric siRNAs for treating androgenetic alopecia

NK-92 with truncated PD-1 shows enhanced therapeutic effects

Dapiglutide attenuates intestinal insufficiency in vivo

Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury

Rare APOE variant gives insight into Alzheimer's pathogenesis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...